A new study from a German research group is likely to fuel concerns about some of the risks associated with prostate biopsy.
Filed under: Diagnosis, Risk | Tagged: biopsy, complications, ED, erectile dysfunction, voiding | 5 Comments »
A new study from a German research group is likely to fuel concerns about some of the risks associated with prostate biopsy.
Filed under: Diagnosis, Risk | Tagged: biopsy, complications, ED, erectile dysfunction, voiding | 5 Comments »
A research team in Belfast, Northern Ireland, has initiated a randomized, controlled clinical trial to assess the impact of diet and exercise on body composition, fatigue, and quality of life for patients who have are about to start androgen deprivation therapy (ADT).
Filed under: Management, Treatment | Tagged: ADT, androgen deprivation, diet, exercise | 2 Comments »
A recent paper in European Urology reports the first (known) case of an “intra-abdominal combustion” during a robot-assisted laparoscopic radical prostatectomy (RALP).
Filed under: Management, Treatment | Tagged: fire, oxygen, RALP, side effect | 1 Comment »
Two newly published articles suggest that – among a small group of Canadian patients and a large cohort of US veterans — there was a significant time interval from initial suspicion of prostate cancer to definitive treatment (where necessary). But was this time interval appropriate?
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: Diagnosis, interval, outcome, prognosis, risk, suspicion, Treatment | Leave a Comment »
A research team at the National Institutes of Health and the Johns Hopkins University Bloomberg School of Public Health is seeking prostate cancer patients willing to complete an on-line survey as part of a study to determine how men with prostate cancer cope with their disease, how their quality of life (QoL) is affected, and [...]
Filed under: Living with Prostate Cancer | Tagged: coping, quality of life, research, survey | 2 Comments »
According to the international Cholesterol Treatment Trialists’ Collaboration, based on data from more than 166,000 clinical trial participants, there is no evidence whatsoever that statin therapy either causes or prevents cancer.
Filed under: Management, Prevention, Treatment, Uncategorized | Tagged: Prevention, risk, statin, Treatment | Leave a Comment »
Biochemical failure (also known as biochemical recurrence) after first-line treatment for prostate cancer is assessed based on a rising PSA level. This is a relatively common event and can happen shortly after first line treatment or many years later. The problem is that we really don’t know how important biochemical recurrence is in an individual [...]
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: biochemical recurrence, comorbidity, Management, risk, survival | Leave a Comment »
The use of androgen deprivation therapy (ADT) alone and in conjunction with other forms of treatment for the management of patients with relatively early stages of prostate cancer (i.e., cancer that is not definitively at least lymph node positive) has been increasingly called into question.
Filed under: Management, Treatment | Tagged: ADT, androgen deprivation therapy | 2 Comments »
Last May, Dan Zenka of the Prostate Cancer Foundation (motivated by his own recent diagnosis) first suggested the idea of lighting the White House blue in September to celebrate Prostate Cancer Awareness Month. Now there’s been a formal request supported by many of the leading prostate cancer advocacy organizations (including Dan and the Prostate Cancer [...]
Filed under: Uncategorized | Tagged: awareness, blue, White House | Leave a Comment »
A new report states that there is minimal evidence of any well-defined effect of diet, nutrition or supplement use on the prevention of prostate cancer based on data collected as part of the Prostate Cancer Prevention Trial (PCPT).
Filed under: Prevention, Risk | Tagged: diet, Prostate Cancer Prevention Trial, risk, supplements | Leave a Comment »
High-intensity focused ultrasound (HIFU) is legally available in Canada as a method for the treatment of prostate cancer. However, a new Canadian practice guideline states that, “HIFU cannot currently be recommended as an alternative to accepted curative treatment approaches for localized prostate cancer.”
Filed under: Management, Treatment | Tagged: guideline, HIFU, high-intensity focused ultrasound | 2 Comments »
For those who haven’t run across it yet, Dana runs a web site called HisProstateCancer.com, aimed primarily at the wives and partners of prostate cancer patients. It’s well worth a visit.
Filed under: Living with Prostate Cancer | Tagged: Bill of Rights, partners, wives | 2 Comments »
In the UK, a nationally developed, on-line decision support tool known as Prosdex is available and is used by at least some men to help them make decisions about whether they wish to undergo PSA testing.
Filed under: Diagnosis, Risk | Tagged: benefit, con, pro, Prosdex, PSA, risk, testing | 2 Comments »
At the beginning of 2010, The “New” Prostate Cancer InfoLink collaborated with a research team at Memorial Sloan-Kettering Cancer Center (MSKCC) to get patient input on the format of web-based feedback pages designed to inform patients about their functional recovery over time after radical prostatectomy (RP) for localized prostate cancer.
Filed under: Living with Prostate Cancer, Management, Uncategorized | Tagged: assessment, fucntional recovery, radical prostatectomy, tool | Leave a Comment »
The “New” Prostate Cancer InfoLink’s daily reports and commentaries can now be monitored through Twitter and/or through Facebook, for those who like to get their news updates on the go. It took us a little while to resolve the technology challenges, but we now seem to be “up and running” on both sites.
Filed under: About Us | Tagged: Facebook, Twitter | 2 Comments »